|
WO2021020455A1
|
|
Vildagliptin-containing dry granulated powder, vildagliptin-containing tablet, and methods for producing these
|
|
WO2021002411A1
|
|
Method for manufacturing orally disintegrating tablet, and orally disintegrating tablet
|
|
JP2020196705A
|
|
Method of stabilizing saxagliptin and powder containing saxagliptin
|
|
JP2020183382A
|
|
Fingolimod hydrochloride-containing preparation and method for producing fingolimod hydrochloride-containing preparation
|
|
WO2020179736A1
|
|
Film coating composition and solid preparation
|
|
JP2020128370A
|
|
Topical nail solution containing efinaconazole
|
|
JP2020015720A
|
|
Imidafenacin-containing tablet and method for producing the same
|
|
JP2020180099A
|
|
Dabigatran etexylate methanesulfonate formulation
|
|
JP2020132600A
|
|
Film-coated tablet and manufacturing method thereof
|
|
US2019231700A1
|
|
Orally disintegrating tablet coated with film
|
|
JP2020070260A
|
|
Teneligliptin-containing pharmaceutical compositions, methods for making the same, teneligliptin-containing tablets and production methods thereof
|
|
JP2020045323A
|
|
Solifenacin succinate-containing preparation
|
|
JP2020018611A
|
|
Method and device for evaluating binding of tablet
|
|
JP2019218313A
|
|
Sustained-release preparation containing pseudoephedrine or pharmaceutically acceptable salt thereof
|
|
JP2019094295A
|
|
Dasatinib Anhydride-Containing Preparation
|
|
JP2018083809A
|
|
Production method of silodosin-containing particles and production method of orally disintegrating tablet containing silodosin
|
|
JP2019089718A
|
|
Limaprost-containing freeze-dried composition and limaprost-containing pharmaceutical composition
|
|
WO2018047789A1
|
|
Orally disintegrating tablet additive composition
|
|
WO2018021265A1
|
|
Additive composition for orally disintegrating tablet
|
|
WO2018021264A1
|
|
Texture evaluation method and texture evaluation apparatus for orally disintegrable test object
|
